LobbyingTexas Medical Association lobbying by quarter
Texas Medical Association's latest lobbying report covers Q2 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Texas Medical Association
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $10K | 1 |
| Q1 2026 | $10K | 1 |
| Q2 2026 | $10K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$150K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Medicare and Medicaid Services (CMS)2 reports
- Health & Human Services, Dept of (HHS)2 reports
- Labor, Dept of (DOL)1 reports
- Treasury, Dept of1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseTexas Medical Association | $150K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | In-house | $10K |
| 04/13for Q1 | In-house | $10K |
| 01/20for Q4 2025 | In-house | $10K |
| 25/10/20for Q3 2025 | In-house | $10K |
| 25/07/21for Q2 2025 | In-house | $10K |
| 25/04/21for Q1 2025 | In-house | $10K |
| 25/01/17for Q4 2024 | In-house | $10K |
| 24/10/16for Q3 2024 | In-house | $10K |
| 24/07/16for Q2 2024 | In-house | $10K |
| 24/04/17for Q1 2024 | In-house | $10K |
| 24/01/18for Q4 2023 | In-house | $10K |
| 23/10/19for Q3 2023 | In-house | $10K |
| 23/07/13for Q2 2023 | In-house | $10K |
| 23/04/19for Q1 2023 | In-house | $10K |
| 23/01/19for Q4 2022 | In-house | $10K |